의료용 체온 모니터링 기기 시장 : 기기 유형, 모니터링 모드, 접속 방식, 전력, 환자 연령층, 용도별 예측(2026-2032년)

The Healthcare Temperature Monitoring Devices Market is projected to grow by USD 4.55 billion at a CAGR of 6.11% by 2032.

Executive Introduction to Healthcare Temperature Monitoring Devices

Healthcare temperature monitoring devices have evolved from basic point-in-time thermometers into connected clinical tools that support diagnosis, infection prevention, perioperative care, neonatal care, remote patient monitoring, and hospital workflow optimization. The category includes digital thermometers, tympanic and temporal artery thermometers, infrared non-contact systems, continuous core temperature probes, wearable patches, and integrated patient monitoring modules.

Demand is supported by the clinical importance of body temperature as a core vital sign and by public health guidance recognizing fever measurement as useful, but not sufficient, as a stand-alone diagnostic screen. Healthcare buyers are prioritizing measurement accuracy, speed, hygiene, interoperability, patient comfort, and regulatory compliance as hospitals, clinics, long-term care facilities, and home care programs shift toward safer, data-enabled care delivery.

Transformative Shifts in the Temperature Monitoring Landscape

The healthcare temperature monitoring devices landscape is being reshaped by the transition from episodic manual measurement to continuous, connected, and workflow-integrated temperature monitoring. Hospitals and clinics increasingly require devices that reduce cross-contamination risk, capture reliable readings across age groups and clinical conditions, and connect with electronic health records, bedside monitors, and remote patient monitoring platforms.

Regulatory expectations are also influencing product strategy. Manufacturers must align with medical device quality systems, electrical safety and electromagnetic compatibility requirements, usability engineering, cybersecurity expectations, and region-specific frameworks such as U.S. FDA requirements and the European Medical Device Regulation. Procurement teams are evaluating total cost of ownership, calibration support, data security, clinical evidence, and service reliability rather than device price alone.

Cumulative Impact of Artificial Intelligence on Temperature Monitoring

Artificial intelligence is adding value to healthcare temperature monitoring by improving signal quality, identifying abnormal temperature trends, and supporting earlier recognition of patient deterioration when temperature data is combined with heart rate, respiratory rate, oxygen saturation, blood pressure, and clinical context. AI-enabled analytics are especially relevant in continuous monitoring, virtual wards, intensive care, post-operative recovery, and post-acute care programs where trend interpretation can be more useful than isolated readings.

The cumulative impact of AI depends on validation, governance, and transparent performance claims. Algorithms used for clinical decision support may fall under software as a medical device expectations, requiring documented risk management, bias assessment, cybersecurity controls, and real-world performance monitoring. AI should enhance clinical workflows, alarm prioritization, and care team awareness while preserving clinician judgment and standardized diagnostic protocols.

Key Regional Insights Across Major Healthcare Markets

Asia-Pacific is supported by expanding hospital infrastructure, large patient populations, rising healthcare expenditure in several economies, and accelerated adoption of digital health in China, India, Japan, South Korea, Australia, and ASEAN markets. Demand is reinforced by infectious disease preparedness, maternal and child health programs, and the need for durable, affordable, and easy-to-use temperature monitoring devices across both urban hospitals and decentralized care settings. North America remains highly focused on connected monitoring, infection control, FDA-cleared technologies, hospital interoperability, and electronic health record integration across acute care, ambulatory care, long-term care, and home health programs.

Europe is shaped by Medical Device Regulation compliance, GDPR-driven data protection, public procurement scrutiny, and strong demand for clinically validated monitoring in acute, long-term, and elderly care environments. Latin America is advancing through public health modernization, private hospital investment, and growing attention to infectious disease surveillance, although service networks and affordability remain important purchasing factors. The Middle East is adopting smart hospital systems, telehealth, and remote monitoring in high-investment health systems, particularly where national health transformation plans prioritize digital care. Africa shows long-term opportunity where robust, low-maintenance, battery-efficient, and affordable devices can strengthen primary care, maternal health, emergency response, and outbreak readiness.

Key Group Insights for Strategic Market Prioritization

ASEAN demand is linked to healthcare access expansion, hospital modernization, medical tourism, and greater use of digital tools in urban medical centers, while rural and community care settings continue to favor durable, affordable, and simple-to-train devices. The GCC is investing in smart hospitals, connected care models, telehealth platforms, and high-quality imported medical technologies, creating opportunities for premium monitoring systems with interoperability, cybersecurity readiness, and strong service support. The European Union emphasizes evidence-based adoption, MDR conformity, privacy-by-design, sustainability, and lifecycle documentation across procurement and post-market surveillance.

BRICS countries represent scale-driven opportunity because of large populations, public hospital procurement, infectious disease surveillance needs, and domestic manufacturing ambitions. G7 markets generally set high benchmarks for clinical evidence, device quality, cybersecurity, interoperability, reimbursement alignment, and patient safety expectations. NATO member countries add demand for resilient medical supply chains, deployable healthcare systems, emergency preparedness, and reliable monitoring technologies for military, humanitarian, disaster response, and civilian healthcare settings.

Key Country Insights for Healthcare Temperature Monitoring Devices

The United States leads in connected patient monitoring, FDA-cleared devices, hospital interoperability, remote care programs, and infection prevention protocols, while Canada prioritizes public health system reliability, procurement quality, patient safety, and equitable access across geographically dispersed communities. Mexico and Brazil show demand across private hospitals, public clinics, emergency care, and infectious disease surveillance needs, with value-based procurement, distributor capability, and service availability influencing purchasing decisions.

In Europe, the United Kingdom emphasizes NHS workflow efficiency, remote monitoring, and standardized procurement; Germany prioritizes high-quality hospital technology, engineering reliability, and regulatory rigor; France focuses on public hospital modernization and connected care; Italy and Spain balance aging populations with cost-sensitive procurement and regional healthcare delivery models; and Russia maintains demand for domestic and imported technologies amid complex supply and regulatory conditions. Across these countries, clinical validation, MDR alignment where applicable, cybersecurity, and data protection remain central to adoption.

China is scaling domestic production, hospital digitization, and connected medical infrastructure, while India is driven by healthcare access expansion, affordability, public health needs, and a fast-growing network of private providers. Japan emphasizes precision, reliability, and aging-care use cases, Australia prioritizes standards-based procurement, remote healthcare delivery, and resilient supply chains, and South Korea combines advanced hospital digitization with strong medical technology capabilities. Each country rewards suppliers that can prove accuracy, usability, compliance, after-sales reliability, training support, and compatibility with established clinical workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated accuracy, fast measurement, hygienic design, patient comfort, and seamless integration with hospital information systems, bedside monitors, and remote patient monitoring platforms. Product portfolios should include both cost-effective devices for high-volume routine care and advanced continuous monitoring solutions for intensive care, perioperative care, neonatal care, emergency care, long-term care, and home-based patient management.

Manufacturers should strengthen regulatory documentation, cybersecurity architecture, calibration programs, usability testing, multilingual training, and post-market surveillance. Commercial teams can improve competitiveness by offering service contracts, localization, distributor training, clinical education, and evidence packages that demonstrate workflow impact, reduced manual documentation burden, infection-control benefits, and compatibility with established clinical protocols.

Research Methodology and Evidence Framework

The research approach combines secondary research from public health agencies, regulatory bodies, standards organizations, clinical literature, procurement trends, healthcare technology adoption indicators, and medical device regulatory databases. Evidence considered includes guidance and publications from organizations such as WHO, CDC, FDA, ECDC, ISO, IEC, and regional medical device authorities where applicable, with emphasis on verified information related to vital sign monitoring, infection prevention, device safety, interoperability, and data protection.

Primary validation should include interviews with clinicians, biomedical engineers, procurement leaders, distributors, regulatory specialists, and device manufacturers. Findings are strengthened through triangulation across regulatory evidence, clinical use cases, product benchmarking, regional healthcare investment patterns, standards alignment, and technology adoption signals to ensure conclusions are practical, current, and decision-ready without relying on unverified estimates or speculative projections.

Conclusion and Strategic Outlook

Healthcare temperature monitoring devices are becoming essential components of modern connected care. Strategic opportunity is strongest where devices combine clinical accuracy, infection-control advantages, interoperability, usability, patient comfort, and compliant data handling. Continuous and wearable solutions are expanding the role of temperature measurement from routine vital sign capture to proactive patient surveillance and trend-based clinical awareness.

The next phase of competition will be defined by evidence, integration, and trust. Organizations that align with regulatory expectations, validate performance across diverse clinical environments, and support healthcare providers with reliable service models will be well positioned to meet demand across hospitals, clinics, long-term care, home care, emergency response, and public health programs.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Healthcare Temperature Monitoring Devices Market, by Device Type

• 7.1. Fixed
  • 7.1.1. Infrared Sensor
  • 7.1.2. Thermistor Probe
• 7.2. Portable
  • 7.2.1. Handheld Thermometer
  • 7.2.2. Thermal Scanner
• 7.3. Wearable
  • 7.3.1. Patch
  • 7.3.2. Smart Watch

8. Healthcare Temperature Monitoring Devices Market, by Monitoring Mode

• 8.1. Continuous
• 8.2. Intermittent

9. Healthcare Temperature Monitoring Devices Market, by Connectivity Type

• 9.1. Wired
• 9.2. Wireless
  • 9.2.1. Bluetooth
  • 9.2.2. Wi-Fi

10. Healthcare Temperature Monitoring Devices Market, by Power Source

• 10.1. Disposable Battery
• 10.2. Rechargeable Battery
• 10.3. AC Powered

11. Healthcare Temperature Monitoring Devices Market, by Patient Age Group

• 11.1. Neonatal
• 11.2. Pediatric
• 11.3. Adult
• 11.4. Geriatric

12. Healthcare Temperature Monitoring Devices Market, by Application

• 12.1. General Ward
• 12.2. Home Healthcare
• 12.3. Intensive Care Unit

13. Healthcare Temperature Monitoring Devices Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Healthcare Temperature Monitoring Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Healthcare Temperature Monitoring Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. 3M Company
• 17.2. American Diagnostic Corporation
• 17.3. Becton, Dickinson and Company
• 17.4. Braun GmbH
• 17.5. Briggs Healthcare
• 17.6. Cadi Scientific
• 17.7. Cardinal Health, Inc.
• 17.8. Dragerwerk AG & Co. KGaA
• 17.9. EarlySense Ltd.
• 17.10. Exergen Corporation
• 17.11. GE HealthCare Technologies Inc.
• 17.12. Gentherm Incorporated
• 17.13. Hicks Thermometers India Limited
• 17.14. Hill-Rom Holdings, Inc.
• 17.15. Kaz USA, Inc.
• 17.16. Koninklijke Philips N.V.
• 17.17. Masimo Corporation
• 17.18. Medtronic plc
• 17.19. Microlife Corporation
• 17.20. Mindray Medical International Limited
• 17.21. Natus Medical Incorporated
• 17.22. Nihon Kohden Corporation
• 17.23. Omron Healthcare, Inc.
• 17.24. Radiometer Medical ApS
• 17.25. Sensitech, Inc.
• 17.26. Spacelabs Healthcare, Inc.
• 17.27. Stryker Corporation
• 17.28. Terumo Corporation
• 17.29. Welch Allyn, Inc.